Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-Jul-20 8:04 PM View:  | Armistice Capital, LLC Director 10% Owner | Tetraphase Pharmaceuticals,... (TTPH) | 28-Jul-20 | Disposition (other) | -- | -- | -- | 0% -- | |
| 29-Jul-20 4:14 PM View: | Gage L Patrick Director | Tetraphase Pharmaceuticals,... (TTPH) | 28-Jul-20 | Disposition (change in control) | 191 | -- | -- | (100%) 0.19K to 0 | |
| 29-Jul-20 4:10 PM View: | Stahl Maria D See Remarks | Tetraphase Pharmaceuticals,... (TTPH) | 28-Jul-20 | Disposition (change in control) | 250 | -- | -- | (100%) 0.25K to 0 | |
| 29-Jul-20 4:18 PM View: | MacDonald Guy Director | Tetraphase Pharmaceuticals,... (TTPH) | 28-Jul-20 | Disposition (change in control) | 15,703 | -- | -- | (100%) 15.7K to 0 | |
| 29-Jul-20 4:18 PM View: | Edwards Larry G. See Remarks Director | Tetraphase Pharmaceuticals,... (TTPH) | 28-Jul-20 | Disposition (change in control) | 1,346 | -- | -- | (100%) 1.34K to 0 | |
| 29-Jul-20 4:14 PM View: | Gage L Patrick Director | Tetraphase Pharmaceuticals,... (TTPH) | 28-Jul-20 | Disposition (change in control) | 1,944 | -- | -- | (91%) 2.13K to 0.19K | |
| 30-Jul-20 8:04 PM View: | Armistice Capital, LLC Director 10% Owner | Tetraphase Pharmaceuticals,... (TTPH) | 28-Jul-20 | Disposition (other) | 1,419,510 | -- | -- | (100%) 1.42M to 0 | |
| 29-Jul-20 5:24 PM View: | la Jolla Pharmaceutical Co 10% Owner | Tetraphase Pharmaceuticals,... (TTPH) | 28-Jul-20 | Purchase | 3,737,360 | $2.00 | $7,474,720.00 | 344% 1.08M to 4.82M | |
| 29-Jul-20 4:27 PM View: | Watt Christopher Senior Vice President, Finance | Tetraphase Pharmaceuticals,... (TTPH) | 28-Jul-20 | Disposition (change in control) | 769 | -- | -- | (100%) 0.77K to 0 | |
| 22-Jun-20 5:16 PM View: | la Jolla Pharmaceutical Co 10% Owner | Tetraphase Pharmaceuticals,... (TTPH) | 19-Jun-20 | Purchase | 234,698 | $2.62 | $613,993.00 | 28% 850.3K to 1.08M | |
| 12-Dec-19 9:35 PM View: | Freund John Gordon Director | Tetraphase Pharmaceuticals,... (TTPH) | 10-Dec-19 | Private Sale | 524 | $2.19 | $1,147.56 | (100%) 0.52K to 0 | |
| 12-Dec-19 9:35 PM View: | Freund John Gordon Director | Tetraphase Pharmaceuticals,... (TTPH) | 10-Dec-19 | Private Sale | 14,507 | $2.19 | $31,770.30 | (97%) 15.03K to 0.52K | |
| 09-Dec-19 5:10 PM View: | MacDonald Guy Director | Tetraphase Pharmaceuticals,... (TTPH) | 06-Dec-19 | Private Sale | 5,735 | $2.25 | $12,903.00 | (96%) 5.98K to 0.25K | |
| 09-Dec-19 5:10 PM View: | MacDonald Guy Director | Tetraphase Pharmaceuticals,... (TTPH) | 05-Dec-19 | Private Sale | 1,870 | $2.34 | $4,376.62 | (24%) 7.86K to 5.99K | |
| 02-Aug-19 4:15 PM View: | Edwards Larry G. President and CEO | Tetraphase Pharmaceuticals,... (TTPH) | 14-May-19 | Grant | 4,148 | -- | -- | 8% 50.79K to 54.94K | |
| 02-Aug-19 4:16 PM View: | Stahl Maria D CBO and General Counsel | Tetraphase Pharmaceuticals,... (TTPH) | 02-Apr-19 | Grant | 13,913 | -- | -- | 59% 23.7K to 37.61K | |
| 02-Aug-19 4:15 PM View: | Edwards Larry G. President and CEO | Tetraphase Pharmaceuticals,... (TTPH) | 02-Apr-19 | Grant | 13,913 | -- | -- | 38% 36.88K to 50.79K | |
| 10-Jan-19 5:18 PM View: | Dumas Jacques Chief ScientificOfficer | Tetraphase Pharmaceuticals,... (TTPH) | 08-Jan-19 | Market Sale (Planned) | 7,497 | $1.60 | $11,995.20 | (100%) 7.5K to 0 | 11% |
| 18-Jan-19 6:04 PM View: | Stahl Maria D SVP and General Counsel | Tetraphase Pharmaceuticals,... (TTPH) | 06-Jan-19 | Grant | 18,698 | -- | -- | 374% 5.0K to 23.7K | |
| 18-Jan-19 6:05 PM View: | Tsai Larry Chief Medical Officer | Tetraphase Pharmaceuticals,... (TTPH) | 06-Jan-19 | Grant | 3,337 | -- | -- | 12% 28.17K to 31.5K | |
| 18-Jan-19 6:01 PM View: | Edwards Larry G. Chief Operating Officer | Tetraphase Pharmaceuticals,... (TTPH) | 06-Jan-19 | Grant | 4,277 | -- | -- | 15% 28.03K to 32.31K | |
| 18-Jan-19 6:06 PM View: | Watt Christopher SVP, Finance | Tetraphase Pharmaceuticals,... (TTPH) | 06-Jan-19 | Grant | 2,668 | -- | -- | 14% 19.11K to 21.78K | |
| 18-Jan-19 6:03 PM View: | MacDonald Guy President and Chief Executive Director | Tetraphase Pharmaceuticals,... (TTPH) | 14-Nov-18 | Grant | 3,332 | -- | -- | 3% 131.06K to 134.4K | |
| 18-Jan-19 6:06 PM View: | Watt Christopher SVP, Finance | Tetraphase Pharmaceuticals,... (TTPH) | 14-Nov-18 | Grant | 3,332 | -- | -- | 14% 23.84K to 27.17K | |
| 18-Jan-19 6:01 PM View: | Edwards Larry G. Chief Operating Officer | Tetraphase Pharmaceuticals,... (TTPH) | 14-Nov-18 | Grant | 2,509 | -- | -- | 7% 34.37K to 36.88K | |
| 18-Jan-19 6:01 PM View: | Edwards Larry G. Chief Operating Officer | Tetraphase Pharmaceuticals,... (TTPH) | 14-May-18 | Grant | 2,058 | -- | -- | 6% 32.31K to 34.37K | |
| 18-Jan-19 6:03 PM View: | MacDonald Guy President and Chief Executive Director | Tetraphase Pharmaceuticals,... (TTPH) | 14-May-18 | Grant | 2,058 | -- | -- | 2% 129.01K to 131.06K | |
| 18-Jan-19 6:06 PM View: | Watt Christopher SVP, Finance | Tetraphase Pharmaceuticals,... (TTPH) | 14-May-18 | Grant | 2,058 | -- | -- | 9% 21.78K to 23.84K | |
| 18-Jan-19 6:05 PM View: | Tsai Larry Chief Medical Officer | Tetraphase Pharmaceuticals,... (TTPH) | 14-May-18 | Grant | 2,058 | -- | -- | 7% 31.5K to 33.56K | |
| 31-Jan-18 4:24 PM View: | Dumas Jacques Chief ScientificOfficer | Tetraphase Pharmaceuticals,... (TTPH) | 30-Jan-18 | Market Option Sale (Planned) | 8,750 | $6.22 | $54,425.00 | (100%) 8.75K to 0 | 83% |
| 31-Jan-18 4:24 PM View: | Dumas Jacques Chief ScientificOfficer | Tetraphase Pharmaceuticals,... (TTPH) | 30-Jan-18 | Option Exercise | 8,750 | $3.69 | $32,287.50 | 100% 0 to 8.75K | |
| 11-Jan-18 4:21 PM View: | Dumas Jacques Chief ScientificOfficer | Tetraphase Pharmaceuticals,... (TTPH) | 09-Jan-18 | Market Sale (Planned) | 7,167 | $6.21 | $44,507.10 | (100%) 7.17K to 0 | 83% |
| 04-Dec-17 9:02 AM View: | Gage L Patrick Director | Tetraphase Pharmaceuticals,... (TTPH) | 29-Nov-17 | Market Purchase | 3,880 | $6.45 | $25,026.00 | 11% 35.0K to 38.88K | (84%) |
| 19-Jan-18 7:44 PM View: | MacDonald Guy President and Chief Executive Director | Tetraphase Pharmaceuticals,... (TTPH) | 14-Nov-17 | Grant | 1,566 | -- | -- | 1% 127.44K to 129.01K | |
| 02-Nov-17 5:33 PM View: | Dumas Jacques Chief ScientificOfficer | Tetraphase Pharmaceuticals,... (TTPH) | 31-Oct-17 | Option Exercise | 8,750 | $3.69 | $32,287.50 | 100% 0 to 8.75K | |
| 02-Nov-17 5:33 PM View: | Dumas Jacques Chief ScientificOfficer | Tetraphase Pharmaceuticals,... (TTPH) | 31-Oct-17 | Market Option Sale (Planned) | 8,750 | $6.03 | $52,762.50 | (100%) 8.75K to 0 | 83% |
| 24-Aug-17 4:48 PM View: | Dumas Jacques Chief ScientificOfficer | Tetraphase Pharmaceuticals,... (TTPH) | 22-Aug-17 | Market Option Sale (Planned) | 17,500 | $6.00 | $105,000.00 | (100%) 17.5K to 0 | 83% |
| 24-Aug-17 4:48 PM View: | Dumas Jacques Chief ScientificOfficer | Tetraphase Pharmaceuticals,... (TTPH) | 22-Aug-17 | Option Exercise | 17,500 | $3.69 | $64,575.00 | 100% 0 to 17.5K | |
| 21-Aug-17 4:15 PM View: | Dumas Jacques Chief ScientificOfficer | Tetraphase Pharmaceuticals,... (TTPH) | 17-Aug-17 | Market Sale (Planned) | 7,155 | $5.86 | $41,928.30 | (100%) 7.16K to 0 | 82% |
| 14-Jun-17 4:07 PM View: | Horn Patrick Taylor Chief Medical Officer | Tetraphase Pharmaceuticals,... (TTPH) | 13-Jun-17 | Option Exercise | 10,000 | $2.03 | $20,300.00 | 100% 0 to 10.0K | |
| 19-Jan-18 7:44 PM View: | MacDonald Guy President and Chief Executive Director | Tetraphase Pharmaceuticals,... (TTPH) | 12-May-17 | Grant | 3,101 | -- | -- | 2% 124.34K to 127.44K | |
| 16-Mar-17 4:22 PM View: | Gage L Patrick Director | Tetraphase Pharmaceuticals,... (TTPH) | 15-Mar-17 | Market Purchase | 10,000 | $7.49 | $74,900.00 | 36% 27.82K to 37.83K | (86%) |
| 16-Mar-17 4:22 PM View: | Gage L Patrick Director | Tetraphase Pharmaceuticals,... (TTPH) | 15-Mar-17 | Market Purchase | 1,000 | $7.47 | $7,470.00 | 3% 37.83K to 38.83K | (86%) |
| 13-Feb-17 4:44 PM View: | MacDonald Guy President and Chief Executive Director | Tetraphase Pharmaceuticals,... (TTPH) | 09-Feb-17 | Option Exercise | 30,378 | $2.90 | $88,096.20 | 32% 93.96K to 124.34K | |
| 01-Feb-17 6:13 PM View: | MacDonald Guy President and Chief Executive Director | Tetraphase Pharmaceuticals,... (TTPH) | 14-Nov-16 | Grant | 3,204 | -- | -- | 4% 90.76K to 93.96K | |
| 19-May-16 7:29 AM View: | Stahl Maria D SVP and General Counsel | Tetraphase Pharmaceuticals,... (TTPH) | 17-May-16 | Grant | 5,000 | $3.82 | $19,100.00 | 200% 2.5K to 7.5K | (74%) |
| 18-May-16 5:37 PM View: | MacDonald Guy President and Chief Executive Director | Tetraphase Pharmaceuticals,... (TTPH) | 16-May-16 | Option Exercise | 25,323 | $0.87 | $22,031.00 | 39% 65.43K to 90.76K | |
| 08-Jan-16 6:36 PM View: | MacDonald Guy President and Chief Executive Director | Tetraphase Pharmaceuticals,... (TTPH) | 06-Jan-16 | Option Exercise | 12,000 | $0.87 | $10,440.00 | 23% 52.0K to 64.0K | |
| 06-Oct-15 4:22 PM View: | Gage L Patrick Director | Tetraphase Pharmaceuticals,... (TTPH) | 02-Oct-15 | Option Exercise | 20,000 | $2.03 | $40,600.00 | 400% 5.0K to 25.0K | |
| 10-Sep-15 9:14 PM View: | Thompson John Craig Chief Operating Officer | Tetraphase Pharmaceuticals,... (TTPH) | 08-Sep-15 | Option Exercise | 10,000 | $14.45 | $144,500.00 | 2915% 0.34K to 10.34K |
